NDC 57377-200-01 - TESTO-200
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 57377-200
- Requested NDC
- 57377-200-01
- Package NDCs from labels
- 57377-200-01
- Manufacturer
- Advanced Pharmaceutical Technology, Inc.
- Effective date
- 2024-10-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Testo-200 inj | Advanced Pharmaceutical Technology, Inc. | 2024-10-30 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 57377-200-01 | 2024-01-30 | C162847 | 48780-1 | 1030e365-6590-111a-e063-dadaa90a10e2 | Testo-200 inj |
DailyMed Dashboard NDC Coverage#
Compounder NDC reports#
| Establishment | FEI | Product NDC | Package NDC | Product | Active ingredients | Reporting period | Normalization |
|---|---|---|---|---|---|---|---|
| "Advanced Pharmaceutical Technology, Inc.(023237884)" | 57377-200 | 57377-200-00 | Testosterone Cypionate | 200 mg/1 mL | 2024-2 | valid | |
| Advanced Pharmaceutical Technology, Inc. | 57377-200 | 57377-200-00 | testosterone cypionate inj. | 200 mg/1 mL | 2024-2 | valid |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Testosterone Cypionate | TESTOSTERONE CYPIONATE | Hospira, Inc. | 6909596e-4bf7-4e11-8029-b89740a30aec | 2025-08-22 | Warnings, Adverse reactions | M0XW1UBI14 |
| testosterone cypionate | TESTOSTERONE CYPIONATE | NorthStar Rx LLC | 9ced69c7-cd37-efb6-1bf9-e21c01e56f5b | 2025-08-05 | Warnings, Adverse reactions | M0XW1UBI14 |
| testosterone cypionate | TESTOSTERONE CYPIONATE | Xiromed LLC | cab949ca-fde9-c5a9-5561-21e98d86d078 | 2025-08-05 | Warnings, Adverse reactions | M0XW1UBI14 |
| AZMIRO | TESTOSTERONE CYPIONATE | Azurity Pharmaceuticals, Inc. | 235b5625-570d-3fba-e063-6394a90aa2d1 | 2025-07-25 | Warnings, Adverse reactions | M0XW1UBI14 |
| Testosterone Cypionate | TESTOSTERONE CYPIONATE | Wilshire Pharmaceuticals | 58ff6e0d-cc0a-4455-8254-d883d26a3b6d | 2025-07-24 | Warnings, Adverse reactions | M0XW1UBI14 |
| Depo-Testosterone | TESTOSTERONE CYPIONATE | Pharmacia & Upjohn Company LLC | 735b5bf3-4464-412c-a072-1bd02f2e5380 | 2025-07-14 | Warnings, Adverse reactions | M0XW1UBI14 |
| testosterone cypionate | TESTOSTERONE CYPIONATE | A-S Medication Solutions | e9d48af3-9514-4dc5-972c-0c1f2547e5c6 | 2025-07-09 | Warnings, Adverse reactions | M0XW1UBI14 |
| 38f35bc1-6359-4ec0-e063-6294a90a659c | 09ffa1bb-23f9-a399-e063-6294a90a7ccd | 2025-07-02 | Warnings, Adverse reactions | 09ffa1bb-23f9-a399-e063-6294a90a7ccd | ||
| Testosterone Cypionate | TESTOSTERONE CYPIONATE | Cipla USA Inc. | b8ac5e07-b7e3-4a60-b0d1-8b1f3ad0c478 | 2025-06-30 | Warnings, Adverse reactions | M0XW1UBI14 |
| Testosterone Cypionate | TESTOSTERONE CYPIONATE | Padagis US LLC | 4195516a-c8e6-457c-b805-43c9a3ca8b77 | 2025-06-03 | Warnings, Adverse reactions | M0XW1UBI14 |
| Testosterone Cypionate | TESTOSTERONE CYPIONATE | Eugia US LLC | f901e2b2-f143-4237-8e95-0d134585490b | 2025-06-03 | Warnings, Adverse reactions | M0XW1UBI14 |
| Testosterone Cypionate | TESTOSTERONE CYPIONATE | Hikma Pharmaceuticals USA Inc. | f60c5520-b336-44a2-95d5-f274939fa595 | 2025-06-01 | Warnings, Adverse reactions | M0XW1UBI14 |
| Testosterone Cypionate | TESTOSTERONE CYPIONATE | Hikma Pharmaceuticals USA Inc. | 5ca67491-4b30-4a47-af0a-be250215d1f0 | 2025-06-01 | Warnings, Adverse reactions | M0XW1UBI14 |
| Testosterone Cypionate | TESTOSTERONE CYPIONATE | Sun Pharmaceutical Industries, Inc. | 3653a602-4551-4e6c-84a7-31861f5dc482 | 2025-05-30 | Warnings, Adverse reactions | M0XW1UBI14 |
| TESTOSTERONE CYPIONATE | TESTOSTERONE CYPIONATE | Cipla USA Inc. | 78d55bad-4a5b-4e21-aeb8-a4c6346208be | 2025-05-09 | Warnings, Adverse reactions | M0XW1UBI14 |
| testosterone cypionate | TESTOSTERONE CYPIONATE | NuCare Pharmaceuticals, Inc. | 346604c7-22d0-60c5-e063-6394a90abf0b | 2025-05-05 | Warnings, Adverse reactions | M0XW1UBI14 |
| testosterone cypionate | TESTOSTERONE CYPIONATE | NuCare Pharmaceuticals,Inc. | 335ff614-15ec-0792-e063-6294a90a2f08 | 2025-04-22 | Warnings, Adverse reactions | M0XW1UBI14 |
| Testosterone Cypionate | TESTOSTERONE CYPIONATE | NuCare pgarmaceuticals,Inc. | 30b453b9-25ef-8262-e063-6394a90a24c2 | 2025-03-19 | Warnings, Adverse reactions | M0XW1UBI14 |
| Testosterone Cypionate | TESTOSTERONE CYPIONATE | Bryant Ranch Prepack | 5a0bba6a-e8da-4b12-af63-eb27b1cca9e6 | 2025-02-04 | Warnings, Adverse reactions | M0XW1UBI14 |
| Chemtox | TRITICUM AESTIVUM, BERBERIS VULGARIS, GLYCYRRHIZA GLABRA, LAPPA MAJOR, RHAMNUS FRANGULA, RHAMNUS PURSHIANA, STILLINGIA SYLVATICA, TRIFOLIUM PRATENSE, XANTHOXYLUM FRAXINEUM, PHYTOLACCA DECANDRA, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, LYMPH NODE (SUIS), THYROIDINUM (SUIS), BELLADONNA, LYCOPODIUM CLAVATUM, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, SALICYLICUM ACIDUM, CORTISONE ACETICUM, EUGENOL, STEARYL ALCOHOL, XYLITOL, FOLLICULINUM, BENZOICUM ACIDUM, CHLORINUM, POTASSIUM SORBATE, | BioActive Nutritional, Inc. | a480e5f4-5f9e-4b23-b257-b0ac1ebfc115 | 2025-01-07 | Warnings | LKG8494WBH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.